International Endocrinology Delegation Visits Sinocare to Explore Innovation and Collaboration in Diabetes Management

From July 14 to 16, 2025, Sinocare Inc. hosted an international delegation of endocrinology experts in Changsha, China. A total of 33 top specialists from Thailand, Indonesia, and the Philippines visited Sinocare’s R&D Center, Manufacturing Center, and Corporate Exhibition Hall. The delegation also engaged in academic exchanges at Xiangya Hospital of Central South University, aiming to jointly explore cutting-edge technologies and global cooperation in diabetes management.

Advancing Chronic Disease Care Through Innovation at Sinocare

On July 14, the delegation received an in-depth tour of Sinocare’s intelligent production lines, innovation-driven R&D center, and digital health management solutions area. Sinocare presented its latest technological breakthroughs, including: the world’s first 15-day calibration-free Continuous Glucose Monitoring (CGM) system, multi-parameter diagnostic devices integrating blood glucose, uric acid, and lipid testing, and a comprehensive digital health management platform.

The experts praised Sinocare’s advancements in precise monitoring and smart healthcare, and engaged in discussions about the application potential of these technologies in Southeast Asian markets. One endocrinologist from the Philippines commented: “Sinocare’s innovations offer more convenient and accurate solutions for diabetes management, which are highly relevant for improving chronic disease control across Southeast Asia.”

Partnering with Xiangya Hospital to Showcase China’s Diabetes Management Ecosystem

As a key clinical partner of Sinocare, Xiangya Hospital of Central South University welcomed the delegation for practical exchanges. Accompanied by the Sinocare team, the experts visited the hospital’s endocrinology department, where they gained insights into its hospital-wide glucose management system and advanced diabetic foot care practices.

Medical experts from Xiangya Hospital shared collaborative research projects and clinical data outcomes developed with Sinocare, demonstrating the value of the “Company + Hospital” model in advancing diabetes diagnosis and treatment capabilities.

The visit highlighted Sinocare’s pivotal role in bridging industry and clinical practice. By integrating technology development with real-world medical applications, Sinocare is accelerating the transformation from standalone products to comprehensive diabetes management solutions.

Deepening Global Collaboration for a Healthier Future

The head of the visiting delegation shared their impressions: “Sinocare has not only demonstrated cutting-edge technological strength, but also built an open and effective international collaboration platform. We look forward to future cooperation in technology transfer, clinical training, and research initiatives.”

The successful visit marks another milestone for Sinocare in global collaboration and technological innovation. Moving forward, Sinocare will continue to lead the industry by working with international partners to advance diabetes care and contribute to global health.